CYP2E1 and head and neck squamous cell carcinoma: There is strong evidence from in vitro studies suggesting that the rare allele of the RsaI/PstI polymorphisms in the CYP2E1 gene probably confers a higher risk of HNSCC susceptibility by increasing transcriptional and enzyme activity [6].